BostonGene Corporation is pioneering the use of biomedical software for advanced patient analysis and personalized therapy decision-making in the fight against cancer. BostonGene’s unique solution performs sophisticated analytics to aid clinicians in their evaluation of viable treatment options for each patient's individual genetics, tumor and tumor microenvironment, clinical characteristics, and disease profile. BostonGene’s mission is to enable physicians to provide every patient with the highest probability of survival through optimal cancer treatments using advanced, personalized therapies.

BostonGene’s intelligent interactive platform assists doctors in finding the most effective strategy for precision cancer therapy. Our system aggregates the latest cancer research and clinical information from around the world. We combine modern technologies, algorithms, and AI to analyze the molecular profiles of patient tumors and deliver all relevant data directly to medical professionals as a comprehensive interactive overview. Our solution optimizes treatment for each patient. The unique BostonGene solution performs integrated analytics to aid clinicians in discovering the best treatment options based on an individual’s genetics, transcriptomics, tumor microenvironment, clinical characteristics, and disease profile. BostonGene partners with doctors to provide every patient with the highest probability of response through the optimization of cancer treatments. The sophisticated analytics of NGS data and integration of scientific and clinical knowledge create unique and personalized therapies.